2010
DOI: 10.3111/13696998.2010.535285 View full text |Buy / Rent full text
|
|

Abstract: The novel test has the potential to provide substantial cost savings for NHS. Even when the novel test's cost is added to the current cost of care, the benefits exceed the additional cost, driven by the test's ability to reduce the rates of false-positive and false-negative diagnoses compared to current standard of care. Potential study limitations include the use of a pooled average of the individual sensitivities and specificities of currently used tests since no data were available on combination testing, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
60
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals